Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock options activity

v3.21.1
Shareholders' Equity (Details) - Schedule of stock options activity - Warrant [Member]
3 Months Ended
Mar. 31, 2021
$ / shares
shares
Shareholders' Equity (Details) - Schedule of stock options activity [Line Items]  
Total Options Outstanding,Beginning Balance (in Shares) | shares 2,668,866
Weighted Average Remaining Term (Years) ,Beginning Balance 8 years 32 days
Weighted Average Exercise Price ,Beginning Balance $ 2.48
Weighted Average Fair Value at Issue ,Beginning Balance $ 1.13
Total Options Outstanding,Outstanding, vested and exercisable (in Shares) | shares 1,493,019
Weighted Average Remaining Term (Years),Outstanding, vested and exercisable 7 years 251 days
Weighted Average Exercise Price,Outstanding, vested and exercisable $ 2.87
Weighted Average Fair Value at Issue ,Outstanding, vested and exercisable (in Shares) | shares 2.08
Total Options Outstanding Issued (in Shares) | shares 918,000
Weighted Average Exercise Price ,Issued $ 2.96
Weighted Average Fair Value at Issue.Issued $ 2.41
Total Options Outstanding,Exercised (in Shares) | shares (10,000)
Weighted Average Exercise Price,Exercised $ 1.45
Weighted Average Fair Value at Issue,Exercised $ 0.66
Total Options Outstanding Ending Balance (in Shares) | shares 3,576,866
Weighted Average Remaining Term (Years),Ending Balance 8 years 138 days
Weighted Average Exercise Price,Ending Balance $ 2.61
Weighted Average Fair Value at Issue,Ending Balance $ 1.94